Rezolute (RZLT) Non-cash Items (2019 - 2026)
Rezolute recorded quarterly Non-cash Items of $3.4 million in Q1 2026, up 36.0% quarter-over-quarter from $2.5 million in Q4 2025, and down 19.05% year-over-year from $4.2 million in Q1 2025.
Rezolute's Non-cash Items history runs 8 years deep, the most recent figure standing at $3.4 million for Q1 2026.
- In Q1 2026, Non-cash Items fell 19.05% year-over-year to $3.4 million; the TTM figure through Mar 2026 stood at $3.4 million (down 19.05% YoY), while the FY2025 annual figure was $14.9 million, up 2.05% from the prior year.
- Non-cash Items came in at $3.4 million for Q1 2026 at Rezolute, up from $2.5 million in the prior quarter.
- In the past five years, Non-cash Items ranged from a high of $72.7 million in Q3 2025 to a low of $100000.0 in Q2 2023.
- A 5-year average of $16.2 million and a median of $14.9 million in 2025 frame the typical range for Non-cash Items.
- Across the five-year window, Non-cash Items surged 47900.0% in 2022 and plunged 99.58% in 2023, its largest moves.
- Rezolute's Non-cash Items stood at $20.2 million in 2022, then sank by 33.17% to $13.5 million in 2023, then soared by 42.22% to $19.2 million in 2024, then tumbled by 86.98% to $2.5 million in 2025, then soared by 36.0% to $3.4 million in 2026.
- According to Business Quant data, Non-cash Items over the past three periods registered $3.4 million, $2.5 million, and $72.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Rezolute | 374.41 Mn | 374.41 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.40 Mn |
| Mar 31, 2026 | 3.40 Mn |
| Dec 31, 2025 | 2.50 Mn |
| Dec 31, 2025 | 2.50 Mn |
| Sep 30, 2025 | 72.70 Mn |
| Sep 30, 2025 | 72.70 Mn |
| Jun 30, 2025 | 14.90 Mn |
| Jun 30, 2025 | 14.90 Mn |
| Mar 31, 2025 | 4.20 Mn |
| Mar 31, 2025 | 4.20 Mn |
| Dec 31, 2024 | 19.20 Mn |
| Dec 31, 2024 | 19.20 Mn |
| Sep 30, 2024 | 19.20 Mn |
| Sep 30, 2024 | 19.20 Mn |
| Jun 30, 2024 | 14.60 Mn |
| Jun 30, 2024 | 14.60 Mn |
| Mar 31, 2024 | 3.60 Mn |
| Mar 31, 2024 | 3.60 Mn |
| Dec 31, 2023 | 13.50 Mn |
| Dec 31, 2023 | 13.50 Mn |
| Sep 30, 2023 | 15.40 Mn |
| Sep 30, 2023 | 15.40 Mn |
| Jun 30, 2023 | 100,000.00 |
| Jun 30, 2023 | 100,000.00 |
| Mar 31, 2023 | 18.80 Mn |
| Mar 31, 2023 | 18.80 Mn |
| Dec 31, 2022 | 20.20 Mn |
| Dec 31, 2022 | 20.20 Mn |
| Sep 30, 2022 | 22.20 Mn |
| Sep 30, 2022 | 22.20 Mn |
| Jun 30, 2022 | 23.90 Mn |
| Jun 30, 2022 | 23.90 Mn |
| Mar 31, 2022 | 6.80 Mn |
| Mar 31, 2022 | 6.80 Mn |
| Dec 31, 2021 | 6.90 Mn |
| Dec 31, 2021 | 6.90 Mn |
| Sep 30, 2021 | 46,250.00 |
| Sep 30, 2021 | 46,250.00 |
| Jun 30, 2021 | 7.90 Mn |
| Jun 30, 2021 | 7.90 Mn |
| Mar 31, 2021 | 46,250.00 |
| Mar 31, 2021 | 46,250.00 |
| Dec 31, 2020 | 2.20 Mn |
| Dec 31, 2020 | 2.20 Mn |
| Sep 30, 2020 | 1.40 Mn |
| Sep 30, 2020 | 1.40 Mn |
| Jun 30, 2020 | 3.40 Mn |
| Jun 30, 2020 | 3.40 Mn |
| Mar 31, 2020 | 4.00 Mn |
| Mar 31, 2020 | 4.00 Mn |
| Dec 31, 2019 | 4.80 Mn |
| Dec 31, 2019 | 4.80 Mn |
| Sep 30, 2019 | 5.30 Mn |
| Sep 30, 2019 | 5.30 Mn |
| Jun 30, 2019 | 2.70 Mn |
| Jun 30, 2019 | 2.70 Mn |